ArticleBMC infectious diseases2026
Early diagnostic performance of real-time PCR versus serology for murine typhus and Q fever in a public health setting.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess the diagnostic performance of real-time PCR compared with conventional serology for murine typhus (MT) and Q fever (QF) in patients with undifferentiated febrile illness (UFI) in an endemic public health setting.
methodsThis secondary analysis was nested within a prospective cross-sectional cohort of UFI conducted in the Canary Islands Health Service (2019-2022). Of 146 eligible patients, 78 fulfilled predefined analytical criteria and were included (39 evaluable for QF and 39 for MT). Real-time PCR was performed 5-10 days after fever onset and prior to antibiotic administration. Serology was performed from day 10 onwards. Sensitivity, specificity, diagnostic timing, and concordance between methods were analysed.
resultsReal-time PCR demonstrated 100% sensitivity and high specificity (96.3% for QF; 75% for MT) under strictly controlled conditions. Median time to molecular diagnosis was 6-7 days, compared with 26-27 days for serology. In a small number of patients, PCR was positive despite negative or inconclusive early serology. Overall, both techniques identified comparable proportions of confirmed cases, although PCR provided earlier microbiological confirmation.
conclusionsReal-time PCR and serology demonstrated comparable diagnostic performance under strictly controlled conditions. However, PCR provided earlier microbiological confirmation, particularly when performed 5-10 days after fever onset and prior to antibiotic administration. These findings support a stage-adapted, complementary diagnostic strategy in endemic settings, whereby molecular testing may be especially useful in patients with early UFI, while serology remains essential at later stages. Larger prospective studies with standardised follow-up would help to further validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.